Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer

Published:2002-06 Issue:6 Volume:109 Page:1188-1191
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Esmaeli Bita,Hortobagyi Gabriel N,Esteva Francisco J,Booser Daniel,Ahmadi M.Amir,Rivera Edgardo,Arbuckle Rebecca,Delpassand Ebrahim,Guerra Laura,Valero Vicente

Publisher

Elsevier BV

Subject

Ophthalmology

Reference10 articles.

1. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer;Hudis;J Clin Oncol,1996

2. Phase II trial of docetaxel. a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer;Valero;J Clin Oncol,1995

3. Docetaxel;Cortes;J Clin Oncol,1995

4. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer;Hainsworth;J Clin Oncol,1998

5. Docetaxel administered on a weekly basis for metastatic breast cancer;Burstein;J Clin Oncol,2000

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association Between Taxane Use and Lacrimal Disorders;Current Eye Research;2023-06-02

2. Nasolacrimal Duct Obstruction in the Patients Receiving Treatment for Cancer;International Ophthalmology Clinics;2023

3. Dacryoendoscopic Findings of Patients with Lacrimal Drainage Obstruction Associated with Cancer Treatment;Korean Journal of Ophthalmology;2022-12-05

4. Canalicular Stenosis Secondary to Chemotherapeutic Agents;Advances in Ophthalmology and Optometry;2021-08

5. Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review;Processes;2021-06-23